Colorado Health Reporter
SEE OTHER BRANDS

Your health and wellness news from Colorado

Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

Press releases published on June 17, 2025

Medical Transcription Services in 2025: Key Trends Transforming the U.S. Market

Medical Transcription Services in 2025: Key Trends Transforming the U.S. Market

DENVER, CO, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- Ditto Transcripts, the industry leader in U.S.-based medical transcription services, today unveiled an extensive report on the evolving landscape of the medical transcription market. The …

Biomea Fusion Announces Proposed Public Offering of Securities

Biomea Fusion Announces Proposed Public Offering of Securities

REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, announced today that it has commenced an underwritten public offering of shares of its common stock and …

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC

Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC

– Veteran executive with over 20 years of oncology leadership and clinical experience with proven track record of success in bringing development candidates through late-stage clinical development – – Company will hold a conference call on July 29 at 4:30  …

Applied Therapeutics Announces Key Leadership Appointments

Applied Therapeutics Announces Key Leadership Appointments

Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhD Dottie Caplan promoted to Executive Vice President, Patient Advocacy and Government Affairs NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. ( …

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and introducing revenue guidance of $12-$16 million for the …

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 15, 2025 it granted stock options to purchase an aggregate of 83,583 shares of common stock and 56,334 restricted stock …

Splash Clinical Introduces SplashBIO™: A Biomarker Platform for Clinical Trials

Splash Clinical Introduces SplashBIO™: A Biomarker Platform for Clinical Trials

WAUWATOSA, Wis., June 17, 2025 (GLOBE NEWSWIRE) -- Splash Clinical, the new standard in trial enrollment, announced today the introduction of SplashBIO™, a proprietary biomarker platform for clinical trials, and an efficient and advanced way for Sponsors …

WeightWatchers’ Reorganization Plan Confirmed, Clears Path for Elimination of Majority of Legacy Debt Burden and Execution of Transformation Plan

WeightWatchers’ Reorganization Plan Confirmed, Clears Path for Elimination of Majority of Legacy Debt Burden and Execution of Transformation Plan

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- WW International, Inc., the global leader in science-backed weight management (“WeightWatchers” or the “Company”), today announced that, following approval of its Plan of Reorganization, it is on track to exit …

Pulmonologists and Rheumatologists Struggle to Diagnose and Manage CTD-ILD, According to New Research from Spherix Global Insights

Pulmonologists and Rheumatologists Struggle to Diagnose and Manage CTD-ILD, According to New Research from Spherix Global Insights

EXTON, PA, June 17, 2025 (GLOBE NEWSWIRE) -- According to Spherix Global Insights’ newly published Special Topix™: Interstitial Lung Disease in Rheumatology (US) report, both rheumatologists and pulmonologists report significant challenges in diagnosing …

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Announces private placement EYEN to become first U.S.-based publicly listed company to hold HYPE in its treasury Hyunsu Jung appointed Chief Investment Officer and Board Member LAGUNA HILLS, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: …

GENFIT: June 17, 2025 Combined Shareholders Meeting Results

GENFIT: June 17, 2025 Combined Shareholders Meeting Results

All resolutions recommended by the Board of Directors approved (quorum: 27.21%). Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to …

GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025

GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025

L’ensemble des projets de résolutions recommandés par le Conseil d’Administration a été approuvé (quorum : 27,21%). Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 17 juin 2025 – GENFIT (Nasdaq et Euronext : GNFT), société …

Dental Care of Stamford announces Breakthrough Bite-Based Treatment During Migraine Awareness Month

Dental Care of Stamford announces Breakthrough Bite-Based Treatment During Migraine Awareness Month

STAMFORD, CT, June 17, 2025 (GLOBE NEWSWIRE) -- As Migraine Awareness Month shines a spotlight on one of the most debilitating chronic conditions in the world, Dr. Jerry Simon, a leading dental expert in craniofacial pain and neuromuscular dentistry, is …

Patient Advocates File Formal Complaints from 50 Patients, Call for Urgent Action to Stop Illegal Fees in Private Clinics

Patient Advocates File Formal Complaints from 50 Patients, Call for Urgent Action to Stop Illegal Fees in Private Clinics

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition was joined by patients from across Ontario in a press conference today as they announced that they have filed formal complaints on behalf of patients charged user fees for health care …

Radiopharmaceuticals Market Set to Grow with 16.4% CAGR from 2024 to 2029

Radiopharmaceuticals Market Set to Grow with 16.4% CAGR from 2024 to 2029

Boston, June 17, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Radiopharmaceuticals: Technologies and Global Markets” is expected to grow from $10.3 billion in 2024 to reach $21.9 billion by the end of 2029, at a compound …

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. Global Phase 2b clinical trial underway evaluating rhu-pGSN …

Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

New York, USA, June 17, 2025 (GLOBE NEWSWIRE) -- Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight  Oligonucleotides are short chains of …

Slimjaro: Examining the Science and Safety of a Legal Slim Jaro Weight loss Health Formula

Slimjaro: Examining the Science and Safety of a Legal Slim Jaro Weight loss Health Formula

Jacksonville, FL, June 17, 2025 (GLOBE NEWSWIRE) -- Weight loss is a humongous challenge that many people struggle with. Lack of motivation to continue a healthy lifestyle, diet, exercise, and hormonal imbalance, pave the path for weight loss supplements …

Compass Health announces 2025 board of directors, bringing together accomplished leaders from regional, industry and nonprofit sectors

Compass Health announces 2025 board of directors, bringing together accomplished leaders from regional, industry and nonprofit sectors

EVERETT, Wash., June 17, 2025 (GLOBE NEWSWIRE) -- Today, Compass Health unveiled its 2025 board of directors, welcoming new members with expertise ranging from art therapy and healthcare marketing to strategic operations and refugee outreach, while tenured …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service